低密度脂蛋白受体单核苷酸多态性与非酒精性脂肪性肝病的相关性

岳海燕; 刘守胜; 王聪; 谷九莲; 辛永宁; 宣世英

doi:10.3969/j.issn.1001-5256.2018.09.021

低密度脂蛋白受体单核苷酸多态性与非酒精性脂肪性肝病的相关性

DOI: 10.3969/j.issn.1001-5256.2018.09.021

1. 大连医科大学
2. 青岛市市立医院消化内二科
3. 青岛市市立医院中心实验室
4. 青岛大学
5. 青岛市市立医院感染科

基金项目:

青岛市市南区科技发展资金项目(2016-3-016-YY)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 2243
- HTML全文浏览量: 51
- PDF下载量: 347
- 被引次数: 0
出版历程
- 收稿日期: 2018-03-28
- 出版日期: 2018-09-20

Association between single nucleotide polymorphism of low-density lipoprotein receptor and nonalcoholic fatty liver disease

Dalian Medical University

Research funding:

摘要

摘要:
目的探讨在中国汉族人群中,低密度脂蛋白受体（LDL-R）的基因多态性与非酒精性脂肪性肝病（NAFLD）的相关性,并评估该基因多态性对血脂水平的影响。方法纳入2015年10月-2017年7月于青岛市市立医院就诊的216例NAFLD患者和135例健康对照组,利用PCR及基因质谱测序检测方法对LDL-R rs1433099和rs2738464位点进行基因型检测。同时利用生物化学方法检测上述受试者血脂水平及肝脏酶谱的变化。通过Hardy-Weinberg（H-W）平衡检验样本的群体代表性,用χ2检验分析基因型的分布是否符合H-W平衡。基因型及等位基因频率采用直接计数法;计数资料组间比较采用χ2检验或Fisher精确检验分析;计量资料组间比较采用t检验和Wilcoxon秩和检验;rs1433099和rs2738464多态性与NAFLD发生的相对风险度以比值比（OR）及其95%可信区间（95%CI）表示,采用二元logistic回归分析模型计算。结果 LDL-R基因rs1433099和rs2738464位点的等位基因频率及基因型分布频率在NAFLD组和健康对照组中差异均无统计学意义（P值均>...
- 非酒精性脂肪性肝病 /
- 受体,LDL /
- 多态性,单核苷酸
Abstract:
Objective To investigate the association between gene polymorphisms of low-density lipoprotein receptor (LDL-R) and nonalcoholic fatty liver disease (NAFLD) and the effect of LDL-R gene polymorphisms on serum lipid levels in the Chinese Han population.Methods A total of 216 NAFLD patients who visited Qingdao Municipal Hospital from October 2015 to July 2017 and 135 healthy subjects were enrolled. PCR and mass spectrometry were used to determine the genotypes of the rs1433099 and rs2738464 loci of LDL-R. The biochemical methods were used to measure the changes in blood lipid levels and liver enzymes. The Hardy-Weinberg (H-W) equilibrium was used to test the group representativeness of samples, and the chi-square test was used to test whether the distribution of genotypes was in accordance with the H-W equilibrium. The direct counting method was used to determine genotype and allele frequencies; the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups; the t-test and wilcoxon rank sum test were used for comparison of continuous data between groups; the association of rs1433099 and rs2738464 polymorphisms with the relative risk of NAFLD was expressed as odds ratio (OR) and its 95% confidence interval (CI) , and the binary logistic regression model was used for calculation. Results There was no significant difference between the NAFLD group and the healthy control group in allele and genotype frequencies of LDL-R rs1433099 and rs2738464 (all P > 0. 05) . There were also no significant differences between the two groups in blood lipid levels, liver enzymes, and body mass index (BMI) (all P > 0. 05) . In the NAFLD group, the healthy control group, and all subjects, there were no significant differences in general clinical features, including blood lipid levels, BMI, blood pressure, and liver enzymes, between the subjects carrying rs1433099 T and rs2738464 G and those who did not carry such alleles (all P > 0. 05) . Conclusion The polymorphisms of LDL-R rs1433099 and rs2738464 do not affect blood lipid levels. This study demonstrates for the first time that the polymorphisms of LDL-R rs1433099 and rs2738464 are not associated with the risk of NAFLD in the Chinese Han population.
- non-alcoholic fatty liver disease /
- polymorphism, single nucleotide /
- receptors, LDL

HTML全文

参考文献(29)

[1]VERNON G, BARANOVA A, YOUNOSSI ZM.Systematic review:The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther, 2011, 34 (3) :274-285.

[2]WEISS J, RAU M, GEIER A.Non-alcoholic fatty liver disease:Epidemiology, clinical course, investigation, and treatment[J].Dtsch Arztebl Int, 2014, 111 (26) :447-452.

[3]LU ZY, SHAO Z, LI YL, et al.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population:An 8-year follow-up study[J].World J Gastroenterol, 2016, 22 (13) :3663-3669.

[4]WONG RJ, AGUILAR M, CHEUNG R, et al.Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J].Gastroenterology, 2015, 148 (3) :547-555.

[5]WRUCK W, GRAFFMANN N, KAWALA MA, et al.Concise review:Current status and future directions on research related to nonalcoholic fatty liver disease[J].Stem Cells, 2017, 35 (1) :89-96.

[6]ZHANG QQ, LU LG.Nonalcoholic fatty liver disease:Dyslipidemia, risk for cardiovascular complications, and treatment strategy[J].J Clin Transl Hepatol, 2015, 3 (1) :78-84.

[7]KATSIKI N, MIKHAILIDIS DP, MANTZOROS CS.Non-alcoholic fatty liver disease and dyslipidemia:An update[J].Metabolism, 2016, 65 (8) :1109-1123.

[8]VAN ZYL T, JERLING JC, CONRADIE KR, et al.Common and rare single nucleotide polymorphisms in the LDLR gene are present in a black South African population and associate with low-density lipoprotein cholesterol levels[J].J Hum Genet, 2014, 59 (2) :88-94.

[9]MUALLEM H, NORTH KE, KAKOKI M, et al.Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the atherosclerosis risk in communities study[J].Hum Genet, 2007, 121 (3-4) :421-431.

[10]PULLINGER CR, HENNESSY LK, CHATTERTON JE, et al.Familial ligand-defective apolipoprotein B.Identification of a new mutation that decreases LDL receptor binding affinity[J].J Clin Invest, 1995, 95 (3) :1225-1234.

[11]FRANCKE U, BROWN MS, GOLDSTEIN JL.Assignment of the human gene for the low density lipoprotein receptor to chromosome19:Synteny of a receptor, a ligand, and a genetic disease[J].Proc Natl Acad Sci U S A, 1984, 81 (9) :2826-2830.

[12]SUDHOF TC, GOLDSTEIN JL, BROWN MS, et al.The LDL receptor gene:A mosaic of exons shared with different proteins[J].Science, 1985, 228 (4701) :815-822.

[13]ZHANG GM, WANG MY, LIU YN, et al.Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility[J].Carcinogenesis, 2017, 38 (12) :1241-1248.

[14]ANAND SS, XIE C, PARE G, et al.Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups:The INTERHEART genetics study[J].Circ Cardiovasc Genet, 2009, 2 (1) :16-25.

[15]TAKEUCHI F, ISONO M, KATSUYA T, et al.Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals[J].PLo S One, 2012, 7 (9) :e46385.

[16]World Medical Association.World Medical Association Declaration of Helsinki:Ethical principles for medical research involving human subjects[J].Jama, 2013, 310 (20) :2191-2194.

[17]RAZAVIZADE M, JAMALI R, ARJ A, et al.Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease[J].Hepatobiliary Pancreat Dis Int, 2012, 11 (5) :513-520.

[18]Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[19]SOOKOIAN S, CASTANO GO, SCIAN R, et al.Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity[J].Hepatology, 2015, 61 (2) :515-525.

[20]CHEN JM, FEREC C, COOPER DN.A systematic analysis of disease-associated variants in the 3'regulatory regions of human protein-coding genes I:General principles and overview[J].Hum Genet, 2006, 120 (1) :1-21.

[21]CONNE B, STUTZ A, VASSALLI JD.The 3'untranslated region of messenger RNA:A molecular'hotspot'for pathology?[J].Nat Med, 2000, 6 (6) :637-641.

[22]KNOUFF C, MALLOY S, WILDER J, et al.Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform[J].J Biol Chem, 2001, 276 (6) :3856-3862.

[23]LEE JD, HSIAO KM, WANG TC, et al.Mutual effect of rs688 and rs5925 in regulating low-density lipoprotein receptor splicing[J].DNA Cell Biol, 2014, 33 (12) :869-875.

[24]CARUZ A, NEUKAM K, RIVERO-JUAREZ A, et al.Association of low-density lipoprotein receptor genotypes with hepatitis C viral load[J].Genes Immun, 2014, 15 (1) :16-24.

[25]LI XL, SUI JQ, LU LL, et al.Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease:A concise review[J].Lipids Health Dis, 2016, 15:53.

[26]ONG JP, PITTS A, YOUNOSSI ZM.Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease[J].J Hepatol, 2008, 49 (4) :608-612.

[27]STEPANOVA M, YOUNOSSI ZM.Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the USpopulation[J].Clin Gastroenterol Hepatol, 2012, 10 (6) :646-650.

[28]LIU H, LU HY.Nonalcoholic fatty liver disease and cardiovascular disease[J].World J Gastroenterol, 2014, 20 (26) :8407-8415.

[29]ONI ET, AGATSTON AS, BLAHA MJ, et al.A systematic review:burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver;should we care?[J].Atherosclerosis, 2013, 230 (2) :258-267.

施引文献

资源附件(0)

访问统计